Consistent with the observation in HepG2 liver cancer cell lines[6], our study showed that inhibiting SLC38A1 expression with siRNA decreased the growth of cultured SH-10-TC cells, thus indicating an overexpression of SLC38A1 contributes to oncogenesis of gastric cancer through promoting cell proliferation. Here, SLC38A1 is linked to liver cancer.